PT2376075E - Formulações nasais de metoclopramida - Google Patents
Formulações nasais de metoclopramida Download PDFInfo
- Publication number
- PT2376075E PT2376075E PT98357965T PT09835796T PT2376075E PT 2376075 E PT2376075 E PT 2376075E PT 98357965 T PT98357965 T PT 98357965T PT 09835796 T PT09835796 T PT 09835796T PT 2376075 E PT2376075 E PT 2376075E
- Authority
- PT
- Portugal
- Prior art keywords
- metoclopramide
- nasal formulations
- nasal
- formulations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M15/00—Inhalators
- A61M15/08—Inhaling devices inserted into the nose
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Hospice & Palliative Care (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14003408P | 2008-12-22 | 2008-12-22 |
Publications (1)
Publication Number | Publication Date |
---|---|
PT2376075E true PT2376075E (pt) | 2015-06-08 |
Family
ID=42283402
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PT98357965T PT2376075E (pt) | 2008-12-22 | 2009-12-22 | Formulações nasais de metoclopramida |
Country Status (8)
Country | Link |
---|---|
US (1) | US8334281B2 (pt) |
EP (1) | EP2376075B1 (pt) |
CA (4) | CA3155873C (pt) |
DK (1) | DK2376075T3 (pt) |
ES (1) | ES2536885T3 (pt) |
PL (1) | PL2376075T3 (pt) |
PT (1) | PT2376075E (pt) |
WO (1) | WO2010075444A2 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20130213393A1 (en) * | 2009-12-22 | 2013-08-22 | Evoke Pharma, Inc. | Nasal formulations of metoclopramide |
PL2747561T3 (pl) * | 2011-08-25 | 2018-11-30 | Evoke Pharma, Inc. | Leczenie objawów związanych z gastroparezą u osobników płci żeńskiej |
EP3554489A4 (en) | 2016-12-15 | 2020-06-17 | Evoke Pharma, Inc. | TREATMENT OF MODERATE AND SERIOUS GASTROPARESIS |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU528310B2 (en) * | 1978-11-16 | 1983-04-21 | Beecham Group Plc | Composition of paracetamol and metoclopramide |
US4624965A (en) * | 1984-11-15 | 1986-11-25 | Nastech Pharmaceutical Co., Inc. | Novel method of administering anti-nausea and anti-emetic pharmaceutical agents and novel dosage forms containing same |
US5578628A (en) * | 1985-06-25 | 1996-11-26 | Glaxo Group Limited | Medicaments for the treatment of nausea and vomiting |
US4729997A (en) * | 1985-10-15 | 1988-03-08 | Nastech Pharmaceutical Co., Inc. | Novel method of administering meclizine type pharmaceutical agents and novel dosage forms containing same |
FR2640139A1 (fr) * | 1988-12-14 | 1990-06-15 | Delagrange Laboratoires | Application de benzamides substitues comme gastromoteurs |
CH681690A5 (en) | 1990-09-28 | 1993-05-14 | Kali Chemie Pharma Gmbh | New metoclopramide salt compsns. with no additives |
US5576317A (en) * | 1994-12-09 | 1996-11-19 | Pfizer Inc. | NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis |
US5760086A (en) | 1996-03-14 | 1998-06-02 | Ribogene, Inc. | Nasal administration of agents for treatment of delayed onset emesis |
US5780431A (en) * | 1996-09-20 | 1998-07-14 | Neurobiological Technologies, Inc. | Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form |
US6187332B1 (en) * | 1999-06-14 | 2001-02-13 | Wisconsin Alumni Research Foundation | Acidic buffered nasal spray |
US6770262B2 (en) * | 2000-03-30 | 2004-08-03 | Questcor Pharmaceuticals, Inc. | Nasal administration of agents for the treatment of gastroparesis |
US6433129B1 (en) * | 2000-11-08 | 2002-08-13 | Millennium Cell, Inc. | Compositions and processes for synthesizing borohydride compounds |
US6586563B1 (en) * | 2001-12-18 | 2003-07-01 | Millennium Cell, Inc. | Processes for synthesizing alkali metal borohydride compounds |
US20100120908A1 (en) | 2007-02-07 | 2010-05-13 | Teika Pharmaceutical Co., Ltd | Eye drop preparation comprising latanoprost |
-
2009
- 2009-12-22 CA CA3155873A patent/CA3155873C/en active Active
- 2009-12-22 ES ES09835796.5T patent/ES2536885T3/es active Active
- 2009-12-22 CA CA2984736A patent/CA2984736C/en active Active
- 2009-12-22 PT PT98357965T patent/PT2376075E/pt unknown
- 2009-12-22 EP EP09835796.5A patent/EP2376075B1/en active Active
- 2009-12-22 PL PL09835796T patent/PL2376075T3/pl unknown
- 2009-12-22 WO PCT/US2009/069298 patent/WO2010075444A2/en active Application Filing
- 2009-12-22 CA CA3224872A patent/CA3224872A1/en active Pending
- 2009-12-22 CA CA2780485A patent/CA2780485C/en active Active
- 2009-12-22 DK DK09835796.5T patent/DK2376075T3/en active
- 2009-12-22 US US12/645,108 patent/US8334281B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
CA2984736A1 (en) | 2010-07-01 |
PL2376075T3 (pl) | 2015-08-31 |
CA3224872A1 (en) | 2010-07-01 |
CA2780485C (en) | 2017-12-12 |
CA3155873C (en) | 2024-03-19 |
EP2376075A4 (en) | 2012-05-30 |
DK2376075T3 (en) | 2015-05-26 |
EP2376075A2 (en) | 2011-10-19 |
WO2010075444A2 (en) | 2010-07-01 |
EP2376075B1 (en) | 2015-04-08 |
ES2536885T3 (es) | 2015-05-29 |
US8334281B2 (en) | 2012-12-18 |
CA2780485A1 (en) | 2010-07-01 |
US20100163032A1 (en) | 2010-07-01 |
CA3155873A1 (en) | 2010-07-01 |
CA2984736C (en) | 2022-07-05 |
WO2010075444A3 (en) | 2010-11-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1253355A1 (zh) | 含有馬西替坦的治療組合物 | |
ZA201200054B (en) | Therapeutic compounds and compositions | |
GB2460523B (en) | Improvements relating to respiratory interface devices | |
ZA201104495B (en) | Conjugates of neurotensin or neurotensin analogs and uses thereof | |
ZA201102604B (en) | Alkylcyclohexylethers of dihydrotetraazabenzoazulenes | |
IL200013A0 (en) | Indenoisoquinolinone analogs and methods of use thereof | |
GB0808835D0 (en) | Therapeutic compositions | |
IL211670A (en) | Preparations containing therapeutic antibodies against steap-1 | |
HK1160925A1 (zh) | 組織蛋白酶 的用途 | |
IL206577A0 (en) | Formulations of flibanserin | |
HK1211207A1 (en) | Improved medicinal aerosol formulations | |
GB0819958D0 (en) | Therapeutic compositions | |
GB0806978D0 (en) | Novel formulations | |
PL2376075T3 (pl) | Donosowe preparaty z metoklopramidu | |
EP2285776A4 (en) | STABILIZATION OF TRIPHENYLBORE-PYRIDINE | |
HK1131039A1 (en) | Pharmaceutical use of sophoricoside | |
IL189405A0 (en) | Stabilization of siva2 | |
EP2331490A4 (en) | PREPARATION OF DIBUTOXYMETHANE | |
EP2282725A4 (en) | NASAL FORMULATIONS OF INSULIN | |
AU330197S (en) | Nasal cleanser | |
HU0800656D0 (en) | Effective use of tea-composition | |
GB0813121D0 (en) | Novel formulations |